Evidence map›Paper›PMID 32705590›Full record

ReviewAdvances in experimental medicine and biology2020

Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Xian-Cheng Jiang

Open access · greenAbstract readReview
In one paragraph

Review in Advances in experimental medicine and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Xian-Cheng JiangDepartment of Cell Biology, SUNY Downstate Health Sciences University, Brooklyn, NY, USA. xian-cheng.jiang@downstate.edu.
SUNY Downstate Health Sciences University · US

Funding

Effect of sphingomyelin biosynthesis on atherosclerosisR01HL149730 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG · 2020 to 2023
$1.9M
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosisR01HL139582 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG · 2018 to 2021
$1.6M
Hepatic PLTP as a target for lowering LDL-cR56HL121409 · NHLBI · SUNY DOWNSTATE MEDICAL CENTER · PI JIANG, XIAN-CHENG, JIN, WEIJUN · 2014 to 2014
$400k
The Effect of SPT Deficiency on AtherosclerosisI01BX000900 · VA · VA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYN · PI JIANG, XIAN-CHENG · 2012 to 2025
–
Teletechnology Accuracy for Real-time Tele-video Assessment of Physical FunctionI01RX000900 · VA · DURHAM VA MEDICAL CENTER · PI HOENIG, HELEN M. · 2015 to 2015
–
BLRD VA I01 BX000900NHLBI NIH HHS R01 HL139582NHLBI NIH HHS R01 HL149730NHLBI NIH HHS R56 HL121409RRD VA I01 RX000900
6 · The paper itself

Abstract

PLTP plays an important role in lipoprotein metabolism and cardiovascular disease development in humans; however, the mechanisms are still not completely understood. In mouse models, PLTP deficiency reduces cardiovascular disease, while its overexpression induces it. Therefore, we used mouse models to investigate the involved mechanisms. In this chapter, the recent main progresses in the field of PLTP research are summarized, and our focus is on the relationship between PLTP and lipoprotein metabolism, as well as PLTP and cardiovascular diseases.

Indexed as

Cardiovascular DiseasesLipid MetabolismPhospholipid Transfer ProteinsAnimalsDisease Models, AnimalHumansMicePhospholipid Transfer ProteinsCardiovascular diseasesHDLLipoproteinPhospholipid transfer proteinVLDL

Identifiers

PMID32705590
PMCPMC8025695
OpenAlexW3045091755

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.